Bioventus Inc. (BVS)

NASDAQ: BVS · IEX Real-Time Price · USD
2.88
-0.05 (-1.71%)
Sep 25, 2023, 9:51 AM EDT - Market open
-1.71%
Market Cap 180.84M
Revenue (ttm) 510.62M
Net Income (ttm) -283.01M
Shares Out 62.79M
EPS (ttm) -4.58
PE Ratio n/a
Forward PE 64.47
Dividend n/a
Ex-Dividend Date n/a
Volume 13,072
Open 2.94
Previous Close 2.93
Day's Range 2.82 - 3.00
52-Week Range 0.80 - 8.29
Beta 0.33
Analysts Hold
Price Target 4.17 (+44.79%)
Earnings Date Nov 7, 2023

About BVS

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for pr... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Feb 11, 2021
Employees 950
Stock Exchange NASDAQ
Ticker Symbol BVS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for BVS stock is "Hold." The 12-month stock price forecast is $4.17, which is an increase of 44.79% from the latest price.

Price Target
$4.17
(44.79% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Bioventus to Present at the Cantor Global Healthcare Conference

DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief f...

5 days ago - GlobeNewsWire

Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Tony Bihl, interim chief executive officer, will ...

18 days ago - GlobeNewsWire

Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance

DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the...

6 weeks ago - GlobeNewsWire

Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference

DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief fi...

7 weeks ago - GlobeNewsWire

Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023

DURHAM, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report fina...

7 weeks ago - GlobeNewsWire

Bioventus Completes Divestiture of its Wound Business

DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has successfully ...

4 months ago - GlobeNewsWire

Bioventus Reports First Quarter Financial Results

DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the ...

4 months ago - GlobeNewsWire

Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023

DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report f...

4 months ago - GlobeNewsWire

Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023

DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the Company plans to file...

4 months ago - GlobeNewsWire

Bioventus Announces Divestiture of its Wound Business

DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has signed a defi...

4 months ago - GlobeNewsWire

Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

DURHAM, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report finan...

5 months ago - GlobeNewsWire

Bioventus Announces CEO Leadership Change

DURHAM, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that Ken M. Reali has stepped...

6 months ago - GlobeNewsWire

Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results

DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for th...

6 months ago - GlobeNewsWire

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has entered int...

6 months ago - GlobeNewsWire

Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023

DURHAM, N.C., March 29, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report...

6 months ago - GlobeNewsWire

Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023

DURHAM, N.C., March 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report fin...

6 months ago - GlobeNewsWire

SHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

NEW YORK , March 13, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ: BVS) and certain officers an...

6 months ago - PRNewsWire

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Bioventus Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / March 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Bioventus Inc. ("Bioventus" o...

7 months ago - Accesswire

BIOVENTUS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Bioventus To Contact Him Directly To Discuss Their Options

NEW YORK , March 11, 2023 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ:...

7 months ago - PRNewsWire

BVS DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important March 13 Deadline in Securities Class Action - BVS

NEW YORK , March 10, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Bioventus Inc. (NASDAQ: BVS): (i) pursuant and/or traceable to the ...

7 months ago - PRNewsWire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming March 13, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investor...

7 months ago - Business Wire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)

LOS ANGELES , March 9, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming  March 13, 2023 deadline to file a lead plaintiff motion in the class action filed on ...

7 months ago - PRNewsWire

BIOVENTUS INC. (NASDAQ: BVS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bioventus Inc. (NASDAQ: BVS)

Did you lose money on investments in Bioventus? If so, please visit Bioventus Inc. Shareholder Class Action Lawsuit or contact  Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your...

7 months ago - PRNewsWire

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Bioventus Inc. (BVS) Investors and Encourages Investors to Contact the Firm Before March 13, 2023

NEW YORK--(BUSINESS WIRE)---- $BVS #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of North Ca...

7 months ago - Business Wire

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

NEW YORK , March 3, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ: BVS) and certain officers and...

7 months ago - PRNewsWire